Business Strategy

EffRx Pharmaceuticals is a lean and agile, integrated, market-oriented biopharma focused on niche therapeutics in Europe and in Switzerland. Our business strategy focuses on successfully shaping the late development and launch of therapeutics for patients suffering from niche and rare diseases.

We tailor the late clinical and regulatory development of niche and orphan medicines to build powerful, differentiated launch propositions, to ensure accelerated market entry and to maximize long term market opportunities.

Our business model centers around providing superior clinical and commercial value propositions for physicians, payers and patients.

Our strategy is to be the preferred EU/Swiss partner and accelerator for late clinical development, approval and valorization of niche/orphan Rx medicines.

 

Contact us for further information.

Additionally, EffRx Pharmaceuticals has a very effective, lean team with proven cross-functional competencies in:

  • Drug Development / IP Management
  • Clinical Development, Medical / Medical Affairs, KOL Management
  • Regulatory Affairs (Filing, Labeling, CMC)
  • Market Access, Marketing, Brand & Launch Management
  • Business Development & Alliance Management
  • Quality Management, Pharmacovigilance
  • Logistics / Supply Chain / Customer Service

EffRx actively seeks collaboration opportunities with small/mid-size
biopharmaceutical companies not having an EU/Swiss set-up and looking to commercialize their medicines in Europe/Switzerland.